US2020299766A1PendingUtilityA1

Compositions and methods for accurately identifying mutations

Assignee: HUTCHINSON FRED CANCER RESPriority: Feb 17, 2012Filed: Jun 10, 2020Published: Sep 24, 2020
Est. expiryFeb 17, 2032(~5.6 yrs left)· nominal 20-yr term from priority
Inventors:Jason H. Bielas
C12N 15/10C12Q 1/6869C12N 15/1065C12N 15/85C12N 15/81C40B 50/06C12N 15/70C40B 40/08C12Q 1/6874C12N 15/1093C12Q 1/6827Y02E50/10
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure provides compositions and methods for accurately detecting mutations by uniquely tagging double stranded nucleic acid molecules with dual cyphers such that sequence data obtained from a sense strand can be linked to sequence when sequenced, for example, by massively parallel sequencing methods.

Claims

exact text as granted — not AI-modified
1 .- 38 . (canceled) 
     
     
         39 . A method of determining an error-corrected sequence of a double-stranded target nucleic acid molecule, comprising:
 (a) ligating the double-stranded target nucleic acid molecule to at least one cypher polynucleotide, to form a cypher-target nucleic acid complex, wherein the at least one cypher polynucleotide comprises:
 (i) a random or partially-random identifier sequence that alone or in combination with an end of the target nucleic acid molecule uniquely labels the double-stranded target nucleic acid molecule; and 
 (ii) a nucleotide sequence that tags each strand of the cypher-target nucleic acid complex such that each strand of the cypher-target nucleic acid complex has a distinct nucleotide sequence relative to its complementary strand; 
   (b) amplifying each strand of the cypher-target nucleic acid complex to produce a plurality of cypher-target amplification products from each of a first strand and a complementary second strand of the cypher-target nucleic acid complex;   (c) sequencing the cypher-target amplification products to produce a plurality of first-strand sequencing reads and a plurality of second-strand sequencing reads; and   (d) comparing the first-strand sequencing reads with the second-strand sequencing reads, and generating an error-corrected sequence of the double-stranded target nucleic acid molecule by distinguishing erroneous nucleotides in one strand that lack a matched base change in the complementary strand.   
     
     
         40 . The method of  claim 39 , wherein the double-stranded target nucleic acid molecule comprises (i) a DNA molecule, or (ii) an RNA molecule. 
     
     
         41 . The method of  claim 39 , wherein the cypher-target nucleic acid complex comprises at least two nucleic acid molecule priming sites. 
     
     
         42 . The method of  claim 39 , wherein the cypher-target nucleic acid complex comprises an identifier sequence on both strands. 
     
     
         43 . The method of  claim 39 , wherein the cypher-target nucleic acid complex comprises an identifier sequence at each end. 
     
     
         44 . The method of  claim 42 , wherein the random or partially-random identifier sequence is double-stranded. 
     
     
         45 . The method of  claim 44 , wherein the random or partially-random identifier sequence comprises about 5 to about 20 nucleotides.

Join the waitlist — get patent alerts

Track US2020299766A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.